Skip to main content

Table 4 Comparison of each test index in thrombosis group and non-thrombosis group of gastric cancer patients

From: Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer

Groups

Non-thrombosis group

Thrombosis group

Z Value

P Value

N

239

54

t-PAIC (ng/mL)

4.43 (2.96,6.33)

5.24 (3.04,17.27)

-0.247

0.014

TM (TU/mL)

7.48 (5.62,10.74)

10.88 (6.85,13.87)

-3.505

<0.001

TAT (ng/mL)

7.67 (5.34,10.96)

16.99 (11.63,26.61)

-8.469

<0.001

PIC (μg/mL)

0.66 (0.45,0.90)

0.88 (0.53,1.48)

-3.113

0.002

D-D (mg/L)

0.75 (0.36,1.85)

1.78 (0.78,5.05)

-3.816

<0.001

FDP (mg/L)

3.20 (2.10,5.80)

6.15 (2.70,16.55)

-3.721

<0.001

  1. Abbreviation: GC Gastric cancer, t-PAIC Tissue plasminogen activator inhibitor complex, TAT Thrombin-antithrombin complex, TM Thrombomodulin, PIC Plasmin-α2-plamininhibitor complex, D-D D-Dimer, FDP Fibrinogen degradation product
  2. * P < 0.05 considered statistically significant